Home » Topics » BioWorld Science

BioWorld Science
RSS

Biogen and Ionis expand strategic collaboration

April 23, 2018

AdAlta redesigns lead candidate for idiopathic pulmonary fibrosis

April 23, 2018

Mission Therapeutics presents novel USP30 inhibitors

April 20, 2018

Medshine Discovery patents MAPK 14 inhibitors

April 20, 2018

Vertex Pharmaceuticals identifies new PAR-2 antagonists

April 20, 2018

Plexxikon divulges novel IDO1 and/or TDO inhibitors

April 20, 2018

Relay Therapeutics and collaborator patent PTP-2C inhibitors

April 20, 2018

EMA committee hands down negative opinion for masitinib in ALS

April 20, 2018

Novel genetically altered broadly neutralizing antibodies protect monkeys from SHIV

April 20, 2018

FDA advisory committee recommends approval of Epidiolex for LGS and Dravet syndrome

April 20, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 22, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...